1
|
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 2023; 402:1648-1659. [PMID: 37778358 DOI: 10.1016/s0140-6736(23)01460-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Revised: 07/07/2023] [Accepted: 07/10/2023] [Indexed: 10/03/2023]
Abstract
BACKGROUND Primary immune thrombocytopenia is an autoimmune disorder mediated partly by platelet autoantibodies, resulting in thrombocytopenia, bleeding, and constitutional symptoms. Efgartigimod, a first-in-class novel human IgG1 Fc fragment, binds the neonatal Fc receptor with high affinity and thus reduces serum IgG concentrations, including autoantibodies. The objective of this study was to evaluate the efficacy and safety of efgartigimod in adults with persistent and chronic primary immune thrombocytopenia. METHODS This phase 3, multicentre, randomised, double-blinded, placebo-controlled, 24-week study evaluated the efficacy and safety of intravenous efgartigimod in adults aged 18 years or older with chronic or persistent primary immune thrombocytopenia who had an average platelet count of less than 30 000, had responded to at least one previous immune thrombocytopenia therapy, and were on a concurrent therapy at baseline or had received at least a second previous immune thrombocytopenia therapy. The study took place in 71 participating sites from Asia, Europe, and North America. Patients were randomly assigned 2:1 to receive either efgartigimod (10 mg/kg) or placebo intravenously for the first 4 weeks, after which the dosing schedule could be altered to once per week or every other week depending on the patients' platelet count. The primary endpoint, evaluated in the chronic population, was sustained platelet count response (≥50 × 109 for at least 4 of the last 6 weeks). This study is registered with ClinicalTrials.gov (NCT04188379) and is completed. FINDINGS A total of 205 patients were screened from Dec 9, 2019, to Feb 3, 2022, and 131 (86 in the efgartigimod group; 45 in the placebo group) were randomly assigned. These patients represented a population with long-term disease who had a mean time since diagnosis of 10·6 years and 67% (88/131) of whom had received at least three previous immune thrombocytopenia treatments. 22% (17/78) of patients with chronic immune thrombocytopenia receiving efgartigimod reached the primary endpoint compared with 5% (2/40) of those receiving placebo (p=0·032; adjusted difference in response, 16% [95% CI 2·6-26·4]). The median number of weeks of disease control in patients with chronic immune thrombocytopenia was 2·0 (IQR 0·0-11·0) for efgartigimod versus 0·0 (0·0-1·0) for placebo (p=0·0009). Efgartigimod was well tolerated; most adverse events were mild to moderate in severity. The most common adverse events of interest in both groups were headache (16% in efgartigimod and 13% in placebo), haematuria (16% in efgartigimod and 16% in placebo), and petechiae (15% in efgartigimod and 27% in placebo). INTERPRETATION Efgartigimod significantly increased sustained platelet count responses compared with placebo in patients with chronic immune thrombocytopenia, including those who had received multiple previous immune thrombocytopenia therapies. Upon completion of the ADVANCE IV study, patients could enroll in the ongoing open-label extension. Subcutaneous efgartigimod is currently being evaluated in patients with immune thrombocytopenia in the ADVANCE SC+ trial. FUNDING argenx.
Collapse
Affiliation(s)
- Catherine M Broome
- Lombardi Cancer Center, Division of Hematology, Georgetown University, Washington, DC, USA.
| | - Vickie McDonald
- Department of Clinical Haematology, Barts Health NHS Trust, London, UK
| | - Yoshitaka Miyakawa
- Department of Hematology, Saitama Medical University Hospital, Saitama, Japan
| | - Monica Carpenedo
- Hematology and Transplant Unit, UOC Hematology and Transplant Unit Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
| | - David J Kuter
- Hematology Division, Massachusetts General Hospital, Boston, MA, USA
| | - Hanny Al-Samkari
- Hematology Division, Massachusetts General Hospital, Boston, MA, USA
| | - James B Bussel
- Division of Hematology and Medical Oncology and Division of Pediatric Hematology and Oncology, Weill Cornell Medical College, New York, NY, USA
| | | | | | | | - Francesco Rodeghiero
- Haematology Project Foundation, Department of Haematology, S Bortolo Hospital, Vicenza, Italy
| | - Marc Michel
- Department of Internal Medicine, National Reference Center for Immune Cytopenias, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France
| | - Adrian Newland
- Centre for Haematology, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, UK
| |
Collapse
|
2
|
Toe LC, Bouckaert KP, De Beuf K, Roberfroid D, Meda N, Thas O, Van Camp J, Kolsteren PW, Huybregts LF. Seasonality modifies the effect of a lipid-based nutrient supplement for pregnant rural women on birth length. J Nutr 2015; 145:634-9. [PMID: 25733482 DOI: 10.3945/jn.114.203448] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Maternal nutritional status is a major determinant of low birth weight and fluctuates across seasons. Seasonality may influence the outcome of prenatal nutrition interventions that aim to enhance fetal growth. OBJECTIVE This study investigated seasonal modifications of the efficacy of a randomized controlled prenatal nutrition intervention trial in pregnant women to improve fetal growth in rural Burkina Faso. METHODS The second Micronutriments et Santé de la Mère et de l'Enfant study compared a lipid-based nutrient supplement (LNS) fortified with multiple micronutrients (MMNs) to an MMN supplement. Truncated Fourier series were used to characterize seasonality in birth outcomes. Models that included the Fourier series and newborn and maternal characteristics were used to assess seasonal effect modifications of prenatal supplementation on birth outcomes. RESULTS Birth weight, birth length, small for gestational age as a proxy for intrauterine growth retardation, and preterm birth were significantly related to date of birth and showed important seasonal variations. LNSs, which supply energy in addition to MMNs, resulted in a significant increase in birth length (+13.5 mm, 95% CI: 6.5, 20.5 mm) at the transition from rain to dry season (September to November) compared to MMNs alone. CONCLUSIONS The climatologic and agricultural seasonal patterns in Burkina Faso affect the efficacy of prenatal LNSs on birth length. In this context, prenatal MMN supplementation programs should be complemented by energy supplementation during the annual rain season to promote fetal growth. This trial was registered at clinicaltrials.gov as NCT00909974.
Collapse
Affiliation(s)
- Laeticia C Toe
- Departments of Food Safety and Food Quality and Centre Muraz, Ministry of Health, Bobo-Dioulasso, Burkina Faso
| | - Kimberley P Bouckaert
- Departments of Food Safety and Food Quality and Nutrition and Child Health Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
| | - Kristof De Beuf
- Mathematical Modeling, Statistics, and Bioinformatics, and FIRE Statistical Consulting, Ghent University, Ghent, Belgium
| | - Dominique Roberfroid
- Nutrition and Child Health Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
| | - Nicolas Meda
- Centre Muraz, Ministry of Health, Bobo-Dioulasso, Burkina Faso
| | - Olivier Thas
- Mathematical Modeling, Statistics, and Bioinformatics, and National Institute for Applied Statistics Research, School of Mathematics and Applied Statistics, University of Wollongong, Wollongong, Australia; and
| | | | - Patrick W Kolsteren
- Departments of Food Safety and Food Quality and Nutrition and Child Health Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
| | - Lieven F Huybregts
- Departments of Food Safety and Food Quality and Nutrition and Child Health Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium; Poverty, Health, and Nutrition Division, International Food Policy Research Institute, Washington, DC
| |
Collapse
|
3
|
Clauw P, Coppens F, De Beuf K, Dhondt S, Van Daele T, Maleux K, Storme V, Clement L, Gonzalez N, Inzé D. Leaf responses to mild drought stress in natural variants of Arabidopsis. Plant Physiol 2015; 167:800-16. [PMID: 25604532 PMCID: PMC4348775 DOI: 10.1104/pp.114.254284] [Citation(s) in RCA: 105] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2014] [Accepted: 01/16/2015] [Indexed: 05/18/2023]
Abstract
Although the response of plants exposed to severe drought stress has been studied extensively, little is known about how plants adapt their growth under mild drought stress conditions. Here, we analyzed the leaf and rosette growth response of six Arabidopsis (Arabidopsis thaliana) accessions originating from different geographic regions when exposed to mild drought stress. The automated phenotyping platform WIWAM was used to impose stress early during leaf development, when the third leaf emerges from the shoot apical meristem. Analysis of growth-related phenotypes showed differences in leaf development between the accessions. In all six accessions, mild drought stress reduced both leaf pavement cell area and number without affecting the stomatal index. Genome-wide transcriptome analysis (using RNA sequencing) of early developing leaf tissue identified 354 genes differentially expressed under mild drought stress in the six accessions. Our results indicate the existence of a robust response over different genetic backgrounds to mild drought stress in developing leaves. The processes involved in the overall mild drought stress response comprised abscisic acid signaling, proline metabolism, and cell wall adjustments. In addition to these known severe drought-related responses, 87 genes were found to be specific for the response of young developing leaves to mild drought stress.
Collapse
Affiliation(s)
- Pieter Clauw
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Frederik Coppens
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Kristof De Beuf
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Stijn Dhondt
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Twiggy Van Daele
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Katrien Maleux
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Veronique Storme
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Lieven Clement
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Nathalie Gonzalez
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| | - Dirk Inzé
- Department of Plant Systems Biology, VIB, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.);Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium (P.C., F.C., S.D., T.V.D., K.M., V.S., N.G., D.I.); andDepartment of Applied Mathematics Computer Science and Statistics (K.D.B., L.C.) and Stat-Gent CRESCENDO, Department of Applied Mathematics and Computer Science (K.D.B.), Ghent University, 9000 Ghent, Belgium
| |
Collapse
|